Global Vasovagal Syncope Treatment Market, By Treatment Type (Medication, Diagnostic Tests), Drug Type (Beta-Blockers, Disopyramide, Scopolamine, Clonidine, Theophylline, Fludrocortisone), Application (Cardiogenic, Neurological, Metabolic, Vasomotor and Others), Route of Administration (Oral, Parenteral, Intravenous), End User (Hospitals, Specialty Clinics, Home and Healthcare), Mode of Purchase (Prescription and Over the Counter), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Others), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028